(Q43310092)

English

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study

scientific article published on August 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 November 2017

Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1434911

26 September 2022

0 references

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

Alan R. Zinsmeister

4

object named as

A R Zinsmeister

1 reference

Europe PubMed Central

19 November 2017

Nicholas Talley

2

object named as

N J Talley

N. J. Talley

2 references

Europe PubMed Central

19 November 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1434911

26 September 2022

author name string

C. J. Steadman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1434911

26 September 2022

S. F. Phillips

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1434911

26 September 2022

language of work or name

0 references

publication date

1 August 1992

1 reference

Europe PubMed Central

19 November 2017

1 reference

Europe PubMed Central

19 November 2017

67

1 reference

Europe PubMed Central

19 November 2017

8

1 reference

Europe PubMed Central

19 November 2017

732-738

1 reference

Europe PubMed Central

19 November 2017

Controlled treatment trials in the irritable bowel syndrome: a critique.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Comparison of rectosigmoid myoelectrical activity in the irritable colon syndrome during relapses and remissions

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Evaluation of colonic myoelectrical activity in health and functional disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Neuronal 5-HT receptors in the periphery.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Diagnostic value of the Manning criteria in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

A patient questionnaire to identify bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Simplified assessment of segmental colonic transit

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

A pharmacological analysis of the mode of action of serotonin (5-hydroxytryptamine) upon the guinea-pig ileum

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

Transit through the proximal colon influences stool weight in the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2960797-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0025-6196(12)60797-6

1 reference

Europe PubMed Central

19 November 2017

1 reference

Europe PubMed Central

19 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43310092&oldid=1936972669"